p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer.

Abstract excerpt

Somatic inactivation of p53 (TP53) mainly occurs as missense mutations that lead to the acquisition of neomorphic mutant protein forms. p53 mutants have been postulated to exert gain-of-function (GOF) effects, including promotion of metastasis and drug tolerance, which generally contribute to the acquisition of the lethal phenotype. Here, by integrating a p53R270H -dependent transcriptomic analysis with chromatin...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chromatin
• Share to Drug Tolerance
• Share to Mutation